| Replantation of 400 avulsed permanent incisors. 4. Factors related to periodontal ligament healing JO Andreasen, MK Borum, HL Jacobsen, FM Andreasen Dental traumatology 11 (2), 76-89, 1995 | 845 | 1995 |
| Replantation of 400 avulsed permanent incisors. 2. Factors related to pulpal healing JO Andreasen, MK Borum, HL Jacobsen, FM Andreasen Dental Traumatology 11 (2), 59-68, 1995 | 405 | 1995 |
| Replantation of 400 avulsed permanent incisors. 1. Diagnosis of healing complications JO Andreasen, MK Borum, HL Jacobsen, FM Andreasen Dental Traumatology 11 (2), 51-58, 1995 | 395 | 1995 |
| Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care UM Lepola, H Loft, EH Reines International clinical psychopharmacology 18 (4), 211-217, 2003 | 302 | 2003 |
| Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. GK Wilcock, CG Ballard, JA Cooper, H Loft The Journal of clinical psychiatry 69 (3), 341-348, 2008 | 244 | 2008 |
| Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis S Gauthier, H Loft, J Cummings International journal of geriatric psychiatry 23 (5), 537-545, 2008 | 242 | 2008 |
| A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder E Alvarez, V Perez, M Dragheim, H Loft, F Artigas International Journal of Neuropsychopharmacology 15 (5), 589-600, 2012 | 208 | 2012 |
| A model of decision-making and information flows for information-intensive agriculture S Fountas, D Wulfsohn, BS Blackmore, HL Jacobsen, SM Pedersen Agricultural Systems 87 (2), 192-210, 2006 | 206 | 2006 |
| Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study S Kasper, DJ Stein, H Loft, R Nil The British journal of psychiatry 186 (3), 222-226, 2005 | 186 | 2005 |
| Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult … JP Boulenger, H Loft, CK Olsen International clinical psychopharmacology 29 (3), 138, 2014 | 177 | 2014 |
| Escitalopram (S‐enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model SA Montgomery, H Loft, C Sánchez, EH Reines, M Papp Pharmacology & toxicology 88 (5), 282-286, 2001 | 177 | 2001 |
| A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD) DS Baldwin, H Loft, M Dragheim European Neuropsychopharmacology 22 (7), 482-491, 2012 | 134 | 2012 |
| Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study S Bakchine, H Loft Journal of Alzheimer's disease 13 (1), 97-107, 2008 | 129 | 2008 |
| A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder. SA Montgomery, R Nil, N Dürr-Pal, H Loft, JP Boulenger The Journal of clinical psychiatry 66 (10), 1270-1278, 2005 | 123 | 2005 |
| A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorder JP Boulenger, H Loft, I Florea Journal of Psychopharmacology 26 (11), 1408-1416, 2012 | 103 | 2012 |
| The effects of vortioxetine on cognitive function in patients with major depressive disorder: a meta-analysis of three randomized controlled trials RS McIntyre, J Harrison, H Loft, W Jacobson, CK Olsen International Journal of Neuropsychopharmacology 19 (10), pyw055, 2016 | 88 | 2016 |
| Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study S Bakchine, H Loft Journal of Alzheimer's Disease 11 (4), 471-479, 2007 | 72 | 2007 |
| A double-blind, controlled study of sertindole versus risperidone in the treatment of moderate-to-severe schizophrenia JM Azorin, N Strub, H Loft International clinical psychopharmacology 21 (1), 49-56, 2006 | 71 | 2006 |
| A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults ME Thase, AR Mahableshwarkar, M Dragheim, H Loft, E Vieta European Neuropsychopharmacology 26 (6), 979-993, 2016 | 63 | 2016 |
| Efficacy of intravenous citalopram compared with oral citalopram for severe depression: safety and efficacy data from a double-blind, double-dummy trial JD Guelfi, N Strub, H Loft Journal of affective disorders 58 (3), 201-209, 2000 | 44 | 2000 |
